Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,506.48
(
-1.51%
)
US TECH 100
23,484.80
(
-0.99%
)
Dow Jones
45,577.47
(
-0.96%
)
Brent Oil
106.93
(
0.00%
)
Bitcoin
70,391.01
(
-0.18%
)
News Focus
News Focus
Post# of 257267
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

genisi

Send PM Follow Ignore
Followers 28
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

genisi

Re: DewDiligence post# 159074

Wednesday, 04/03/2013 3:09:31 AM

Wednesday, April 03, 2013 3:09:31 AM

Post# of 257267

The Teva-Lonza FoB collaboration announced in 2009 (#msg-34930012) appears to be dead, for all practical purposes

After the discontinuation of TL011 (the JV's Rituxan knockoff) phase III in Oct 2012, and the hardly mentioned FoB program on Teva's analyst day in Dec 2012, it's not surprising.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today